Literature DB >> 12922946

Established criteria for disease controlling drugs in ankylosing spondylitis.

D D Gladman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12922946      PMCID： PMC1754660          DOI： 10.1136/ard.62.9.793

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  16 in total

Review 1.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 2.  The heart in ankylosing spondylitis.

Authors:  T W O'Neill; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis.

Authors:  M Stone; D Salonen; M Lax; U Payne; V Lapp; R Inman
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

4.  Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study.

Authors:  D O Clegg; D J Reda; M H Weisman; W D Blackburn; J J Cush; G W Cannon; M L Mahowald; H R Schumacher; T Taylor; E Budiman-Mak; M R Cohen; F B Vasey; M E Luggen; E Mejias; S L Silverman; R Makkena; F P Alepa; J Buxbaum; C M Haakenson; R H Ward; B J Manaster; R J Anderson; J R Ward; W G Henderson
Journal:  Arthritis Rheum       Date:  1996-12

5.  The effects of comprehensive home physiotherapy and supervision on patients with ankylosing spondylitis--an 8-month followup.

Authors:  G Kraag; B Stokes; J Groh; A Helewa; C H Goldsmith
Journal:  J Rheumatol       Date:  1994-02       Impact factor: 4.666

6.  The natural disease course of ankylosing spondylitis.

Authors:  S Carette; D Graham; H Little; J Rubenstein; P Rosen
Journal:  Arthritis Rheum       Date:  1983-02

7.  Meta-analysis of sulfasalazine in ankylosing spondylitis.

Authors:  M B Ferraz; P Tugwell; C H Goldsmith; E Atra
Journal:  J Rheumatol       Date:  1990-11       Impact factor: 4.666

8.  An epidemiological survey of the signs and symptoms of ankylosing spondylitis.

Authors:  J T Gran
Journal:  Clin Rheumatol       Date:  1985-06       Impact factor: 2.980

Review 9.  Clinical aspects of the spondyloarthropathies.

Authors:  D D Gladman
Journal:  Am J Med Sci       Date:  1998-10       Impact factor: 2.378

10.  Radiology of seronegative spondyloarthropathies.

Authors:  D Resnick
Journal:  Clin Orthop Relat Res       Date:  1979-09       Impact factor: 4.176
View more
  3 in total

Review 1.  Rationale of using different biological therapies in rheumatoid arthritis.

Authors:  Matthias Geyer; Ulf Müller-Ladner
Journal:  Arthritis Res Ther       Date:  2010-08-24       Impact factor: 5.156

2.  [Effectiveness and safety of radium chloride in the treatment of ankylosing spondylitis. Results of an observational study].

Authors:  A Alberding; H Stierle; J Brandt; J Braun
Journal:  Z Rheumatol       Date:  2006-05       Impact factor: 1.372

Review 3.  Infliximab: 12 years of experience.

Authors:  Josef S Smolen; Paul Emery
Journal:  Arthritis Res Ther       Date:  2011-05-25       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.